People: Synta Pharmaceuticals Corp (SNTA.OQ)

SNTA.OQ on NASDAQ Stock Exchange Global Market

3.18USD
21 Nov 2014
Price Change (% chg)

$0.09 (+2.91%)
Prev Close
$3.09
Open
$3.13
Day's High
$3.18
Day's Low
$3.07
Volume
260,814
Avg. Vol
394,858
52-wk High
$7.22
52-wk Low
$2.62

Search Stocks

Gollust, Keith 

Brief Biography

Mr. Keith R. Gollust was Chairman of the Board of Synta Pharmaceuticals Corp. Mr. Gollust has been a member of Board of Directors since July 2002 and has been Chairman since September 2002. Mr. Gollust is a private investor and President of Gollust Management, Inc., the general partner of Wyandanch Partners, an investment partnership. In the past, Mr. Gollust has served as a director of numerous public and private companies. Mr. Gollust currently serves as a director of CastleLine Holdings, LLC, an insurance holding company and Script Relief, LLC, a discount prescription drug company. He also is a member of the Board of Trustees of The Julliard School. Mr. Gollust received a B.A. from Princeton University and an MSIA from Carnegie Mellon University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Keith Gollust

--

Anne Whitaker

--

Keith Ehrlich

763,897

Arthur McMahon

--

Vojo Vukovic

900,181

Wendy Rieder

622,938
As Of 30 Dec 2013
Search Stocks